Tokuyama M and Mabuchi T: New treatment addressing the pathogenesis of psoriasis. Int J Mol Sci. 21(7488)2020.PubMed/NCBI View Article : Google Scholar

Griffiths CE and Barker JN: Pathogenesis and clinical features of psoriasis. Lancet. 370:263–271. 2007.PubMed/NCBI View Article : Google Scholar

Nestle FO, Kaplan DH and Barker J: Psoriasis. N Engl J Med. 361:496–509. 2009.PubMed/NCBI View Article : Google Scholar

Parisi R, Symmons DPM, Griffiths CE and Ashcroft DM: Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: A systematic review of incidence and prevalence. J Invest Dermatol. 133:377–385. 2013.PubMed/NCBI View Article : Google Scholar

Rachakonda TD, Schupp CW and Armstrong AW: Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 70:512–516. 2014.PubMed/NCBI View Article : Google Scholar

Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM and Ashcroft DM: Global Psoriasis Atlas. National, regional, and worldwide epidemiology of psoriasis: Systematic analysis and modelling study. BMJ. 369(m1590)2020.PubMed/NCBI View Article : Google Scholar

Michalek IM, Loring B and John SM: A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 31:205–212. 2017.PubMed/NCBI View Article : Google Scholar

Dand N, Mahil SK, Capon F, Smith CH, Simpson MA and Barker JN: Psoriasis and Genetics. Acta Derm Venereol. 100(adv00030)2020.PubMed/NCBI View Article : Google Scholar

O'Rielly DD, Jani M, Rahman P and Elder JT: The genetics of psoriasis and psoriatic arthritis. J Rheumatol. (Suppl 95):46–50. 2019.PubMed/NCBI View Article : Google Scholar

Weiss G, Shemer A and Trau H: The Koebner phenomenon: Review of the literature. J Eur Acad Dermatol Venereol. 16:241–248. 2002.PubMed/NCBI View Article : Google Scholar

Malhotra SK and Mehta V: Role of stressful life events in induction or exacerbation of psoriasis and chronic urticaria. Indian J Dermatol Venereol Leprol. 74:594–599. 2008.PubMed/NCBI View Article : Google Scholar

Basavaraj KH, Ashok NM, Rashmi R and Praveen TK: The role of drugs in the induction and/or exacerbation of psoriasis. Int J Dermatol. 49:1351–1361. 2010.PubMed/NCBI View Article : Google Scholar

Fry L and Baker BS: Triggering psoriasis: The role of infections and medications. Clin Dermatol. 25:606–615. 2007.PubMed/NCBI View Article : Google Scholar

Higgins E: Alcohol, smoking and psoriasis. Clin Exp Dermatol. 25:107–110. 2000.PubMed/NCBI View Article : Google Scholar

Armstrong AW, Harskamp CT and Armstrong EJ: The association between psoriasis and obesity: A systematic review and meta-analysis of observational studies. Nutr Diabetes. 2(e54)2012.PubMed/NCBI View Article : Google Scholar

Balato N, Di Costanzo L, Patruno C, Patrì A and Ayala F: Effect of weather and environmental factors on the clinical course of psoriasis. Occup Environ Med. 70(600)2013.PubMed/NCBI View Article : Google Scholar

López-Estebaranz JL, Sánchez-Carazo JL and Sulleiro S: Effect of a family history of psoriasis and age on comorbidities and quality of life in patients with moderate to severe psoriasis: Results from the ARIZONA study. J Dermatol. 43:395–401. 2016.PubMed/NCBI View Article : Google Scholar

Duffy DL, Spelman LS and Martin NG: Psoriasis in Australian twins. J Am Acad Dermatol. 29:428–434. 1993.PubMed/NCBI View Article : Google Scholar

Trembath RC, Clough RL, Rosbotham JL, Jones AB, Camp RD, Frodsham A, Browne J, Barber R, Terwilliger J, Lathrop GM and Barker JN: Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet. 6:813–820. 1997.PubMed/NCBI View Article : Google Scholar

Sagoo GS, Tazi-Ahnini R, Barker JWN, Elder JT, Nair RP, Samuelsson L, Traupe H, Trembath RC, Robinson DA and Iles MM: Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-q31 in Caucasian and Chinese Hans population. J Invest Dermatol. 122:1401–1405. 2004.PubMed/NCBI View Article : Google Scholar

Chen L and Tsai TF: HLA-Cw6 and psoriasis. Br J Dermatol. 178:854–862. 2018.PubMed/NCBI View Article : Google Scholar

Umapathy S, Pawar A, Mitra R, Khuperkar D, Devaraj JP, Ghosh K and Khopkar U: Hla-a and Hla-B alleles associated in psoriasis patients from Mumbai, Western India. Indian J Dermatol. 56:497–500. 2011.PubMed/NCBI View Article : Google Scholar

Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ, et al: Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet. 41:199–204. 2009.PubMed/NCBI View Article : Google Scholar

Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, et al: A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 80:273–290. 2007.PubMed/NCBI View Article : Google Scholar

Garcia VE, Chang M, Brandon R, Li Y, Matsunami N, Callis-Duffin KP, Civello D, Rowland CM, Bui N, Catanese JJ, et al: Detailed genetic characterization of the interleukin-23 receptor in psoriasis. Genes Immun. 9:546–555. 2008.PubMed/NCBI View Article : Google Scholar

Hasegawa H, Mizoguchi I, Chiba Y, Ohashi M, Xu M and Yoshimoto T: Expanding diversity in molecular structures and functions of the IL-6/IL-12 heterodimeric cytokine Family. Front Immunol. 7(479)2016.PubMed/NCBI View Article : Google Scholar

Onoufriadis A, Simpson MA, Pink AE, Di Meglio P, Smith CH, Pullabhatla V, Knight J, Spain SL, Nestle FO, Burden AD, et al: Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 89:432–437. 2011.PubMed/NCBI View Article : Google Scholar

Cullen G, Kroshinsky D, Cheifetz AS and Korzenik JR: Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: A new series and a review of 120 cases from the literature. Aliment Pharmacol Ther. 34:1318–1327. 2011.PubMed/NCBI View Article : Google Scholar

Pugliese D, Guidi L, Ferraro PM, Marzo M, Felice C, Celleno L, Landi R, Andrisani G, Pizzolante F, De Vitis I, et al: Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study. Aliment Pharmacol Ther. 42:880–888. 2015.PubMed/NCBI View Article : Google Scholar

Eickstaedt JB, Killpack L, Tung J, Davis D, Hand JL and Tollefson MM: Psoriasis and psoriasiform eruptions in pediatric patients with inflammatory bowel disease treated with Anti-tumor necrosis factor alpha agents. Pediatr Dermatol. 34:253–260. 2017.PubMed/NCBI View Article : Google Scholar

Famenini S and Wu JJ: Infliximab-induced psoriasis in treatment of Crohn's disease-associated ankylosing spondylitis: Case report and review of 142 cases. J Drugs Dermatol. 12:939–943. 2013.PubMed/NCBI

Filoni A, Vestita M, Congedo M, Giudice G, Tafuri S and Bonamonte D: Association between psoriasis and vitamin D: Duration of disease correlates with decreased vitamin D serum levels: An observational case-control study. Medicine (Baltimore). 97(e11185)2018.PubMed/NCBI View Article : Google Scholar

Orgaz-Molina J, Buendía-Eisman A, Arrabal-Polo MA, Ruiz JC and Arias-Santiago S: Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: A case-control study. J Am Acad Dermatol. 67:931–938. 2012.PubMed/NCBI View Article : Google Scholar

Porumb-Andrese E, Vâță D, Postolică R, Stătescu L, Stătescu C, Grăjdeanu AI, Pătrașcu AI, Popescu IA and Solovastru LG: Association between personality type, affective distress profile and quality of life in patients with psoriasis vs. patients with cardiovascular disease. Exp Ther Med. 18:4967–4973. 2019.PubMed/NCBI View Article : Google Scholar

Cai Y, Fleming C and Yan J: New insights of T cells in the pathogenesis of psoriasis. Cell Mol Immunol. 9:302–309. 2012.PubMed/NCBI View Article : Google Scholar

Coimbra S, Figueiredo A, Castro E, Rocha-Pereira P and Santos-Silva A: The roles of cells and cytokines in the pathogenesis of psoriasis. Int J Dermatol. 51:389–395. 2012.PubMed/NCBI View Article : Google Scholar

Boehncke WH: Etiology and pathogenesis of psoriasis. Rheum Dis Clin North Am. 41:665–675. 2015.PubMed/NCBI View Article : Google Scholar

Lai Y and Gallo RL: AMPed up immunity: How antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30:131–141. 2009.PubMed/NCBI View Article : Google Scholar

Ogawa E, Sato Y, Minagawa A and Okuyama R: Pathogenesis of psoriasis and development of treatment. J Dermatol. 45:264–272. 2018.PubMed/NCBI View Article : Google Scholar

Rendon A and Schäkel K: Psoriasis pathogenesis and treatment. Int J Mol Sci. 20(1475)2019.PubMed/NCBI View Article : Google Scholar

Eckert RL, Broome AM, Ruse M, Robinson N, Ryan D and Lee K: S100 proteins in the epidermis. J Invest Dermatol. 123:23–33. 2004.PubMed/NCBI View Article : Google Scholar

Büchau AS and Gallo RL: Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol. 25:616–624. 2007.PubMed/NCBI View Article : Google Scholar

Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M and Fouser LA: Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 203:2271–2279. 2006.PubMed/NCBI View Article : Google Scholar

Jinquan T, Vorum H, Larsen CG, Madsen P, Rasmussen HH, Gesser B, Etzerodt M, Honoré B, Celis JE and Thestrup-Pedersen K: Psoriasin: A novel chemotactic protein. J Invest Dermatol. 107:5–10. 1996.PubMed/NCBI View Article : Google Scholar

Harder J and Schröder JM: Psoriatic scales: A promising source for the isolation of human skin-derived antimicrobial proteins. J Leukoc Biol. 77:476–486. 2005.PubMed/NCBI View Article : Google Scholar

Morizane S and Gallo RL: Antimicrobial peptides in the pathogenesis of psoriasis. J Dermatol. 39:225–230. 2012.PubMed/NCBI View Article : Google Scholar

Frohm M, Agerberth B, Ahangari G, Stâhle-Bäckdahl M, Lidén S, Wigzell H and Gudmundsson G: The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem. 272:15258–15263. 1997.PubMed/NCBI View Article : Google Scholar

Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, Homey B, Cao W, Wang YH, Su B, Nestle FO, et al: Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature. 449:564–569. 2007.PubMed/NCBI View Article : Google Scholar

Morizane S, Yamasaki K, Mühleisen B, Kotol PF, Murakami M, Aoyama Y, Iwatsuki K, Hata T and Gallo RL: Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 Ligands. J Invest Dermatol. 132:135–143. 2012.PubMed/NCBI View Article : Google Scholar

Hänsel A, Günther C, Ingwersen J, Starke J, Schmitz M, Bachmann M, Meurer M, Rieber EP and Schäkel K: Human slan (6-sulfo LacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong Th17/Th1 T-cell responses. J Allergy Clin Immunol. 127:787–794.e1-e9. 2011.PubMed/NCBI View Article : Google Scholar

Mabuchi T and Hirayama N: Binding affinity and interaction of LL-37 with HLA-C*06:02 in psoriasis. J Invest Dermatol. 136:1901–1903. 2016.PubMed/NCBI View Article : Google Scholar

Arakawa A, Siewert K, Stöhr J, Besgen P, Kim SM, Rühl G, Nickel J, Vollmer S, Thomas P, Krebs S, et al: Melanocyte antigen triggers autoimmunity in human psoriasis. J Exp Med. 212:2203–2212. 2015.PubMed/NCBI View Article : Google Scholar

Krueger JG: An autoimmune ‘attack’ on melanocytes triggers psoriasis and cellular hyperplasia. J Exp Med. 212:2186. 2015.PubMed/NCBI View Article : Google Scholar

Nishimoto S, Kotani H, Tsuruta S, Shimizu N, Ito M, Shichita T, Morita R, Takahashi H, Amagai M and Yoshimura A: Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation. J Immunol. 191:3065–3072. 2013.PubMed/NCBI View Article : Google Scholar

Chiricozzi A, Romanelli P, Volpe E, Borsellino G and Romanelli M: Scanning the immunopathogenesis of psoriasis. Int J Mol Sci. 19(E179)2018.PubMed/NCBI View Article : Google Scholar

Fuentes-Duculan J, Bonifacio KM, Hawkes JE, Kunjravia N, Cueto I, Li X, Gonzalez J, Garcet S and Krueger JG: Autoantigens ADAMTSL5 and LL37 are significantly upregulated in active Psoriasis and localized with keratinocytes, dendritic cells and other leukocytes. Exp Dermatol. 26:1075–1082. 2017.PubMed/NCBI View Article : Google Scholar

Bonifacio KM, Kunjravia N, Krueger JG and Duculan JF: Cutaneous expression of A Disintegrin-like and Metalloprotease domain containing thrombospondin type 1 motif-like 5 (ADAMTSL5) in psoriasis goes beyond Melanocytes. J Pigment Disord. 3(244)2016.PubMed/NCBI View Article : Google Scholar

Liu YJ: IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol. 23:275–306. 2005.PubMed/NCBI View Article : Google Scholar

Benhadou F, Mintoff D and Del Marmol V: Psoriasis: Keratinocytes or immune cells-which is the trigger? Dermatology. 235:91–100. 2019.PubMed/NCBI View Article : Google Scholar

Nestle FO, Conrad C, Tun-Kyi A, Homey B, Gombert M, Boyman O, Burg G, Liu YJ and Gilliet M: Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med. 202:135–143. 2005.PubMed/NCBI View Article : Google Scholar

van der Fits L, van der Wel LI, Laman JD, Prens EP and Verschuren MCM: In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered. J Invest Dermatol. 122:51–60. 2004.PubMed/NCBI View Article : Google Scholar

Gilliet M, Conrad C, Geiges M, Cozzio A, Thürlimann W, Burg G, Nestle FO and Dummer R: Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol. 140:1490–1495. 2004.PubMed/NCBI View Article : Google Scholar

Vinter H, Iversen L, Steiniche T, Kragballe K and Johansen C: Aldara^®-induced skin inflammation: Studies of patients with psoriasis. Br J Dermatol. 172:345–353. 2015.PubMed/NCBI View Article : Google Scholar

Takeda K, Kaisho T and Akira S: Toll-like receptors. Annu Rev Immunol. 21:335–376. 2003.PubMed/NCBI View Article : Google Scholar

Honda K, Ohba Y, Yanai H, Negishi H, Mizutani T, Takaoka A, Taya C and Taniguchi T: Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature. 434:1035–1040. 2005.PubMed/NCBI View Article : Google Scholar

Lande R, Botti E, Jandus C, Dojcinovic D, Fanelli G, Conrad C, Chamilos G, Feldmeyer L, Marinari B, Chon S, et al: The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis. Nat Commun. 5(5621)2014.PubMed/NCBI View Article : Google Scholar

Farkas A and Kemény L: Interferon-α in the generation of monocyte-derived dendritic cells: Recent advances and implications for dermatology. Br J Dermatol. 165:247–254. 2011.PubMed/NCBI View Article : Google Scholar

Lowes MA, Chamian F, Abello MV, Fuentes-Duculan J, Lin SL, Nussbaum R, Novitskaya I, Carbonaro H, Cardinale I, Kikuchi T, et al: Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA. 102:19057–19062. 2005.PubMed/NCBI View Article : Google Scholar

Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suárez-Fariñas M, Fuentes-Duculan J, Novitskaya I, Khatcherian A, Bluth MJ, Lowes MA and Krueger JG: Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med. 204:3183–3194. 2007.PubMed/NCBI View Article : Google Scholar

Zaba LC, Krueger JG and Lowes MA: Resident and ‘inflammatory’ dendritic cells in human skin. J Invest Dermatol. 129:302–308. 2009.PubMed/NCBI View Article : Google Scholar

Martini E, Wikén M, Cheuk S, Gallais Sérézal I, Baharom F, Ståhle M, Smed-Sörensen A and Eidsmo L: Dynamic changes in resident and infiltrating epidermal dendritic cells in active and resolved psoriasis. J Invest Dermatol. 137:865–873. 2017.PubMed/NCBI View Article : Google Scholar

McKenzie BS, Kastelein RA and Cua DJ: Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27:17–23. 2006.PubMed/NCBI View Article : Google Scholar

Wang F, Lee E, Lowes MA, Haider AS, Fuentes-Duculan J, Abello MV, Chamian F, Cardinale I and Krueger JG: Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: Gene regulation and cellular effects. J Invest Dermatol. 126:1590–1599. 2006.PubMed/NCBI View Article : Google Scholar

Nickoloff BJ: The cytokine network in psoriasis. Arch Dermatol. 127:871–884. 1991.PubMed/NCBI

Reich K, Nestle FO, Papp K, Ortonne JP, Evans R, Guzzo C, Li S, Dooley LT and Griffiths CE: EXPRESS study investigators. Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: A phase III, multicentre, double-blind trial. Lancet. 366:1367–1374. 2005.PubMed/NCBI View Article : Google Scholar

Yao Y, Richman L, Morehouse C, de los Reyes M, Higgs BW, Boutrin A, White B, Coyle A, Krueger J, Kiener PA and Jallal B: Type I interferon: Potential therapeutic target for psoriasis? PLoS One. 3(e2737)2008.PubMed/NCBI View Article : Google Scholar

Funk J, Langeland T, Schrumpf E and Hanssen LE: Psoriasis induced by interferon-alpha. Br J Dermatol. 125:463–465. 1991.PubMed/NCBI View Article : Google Scholar

Ketikoglou I, Karatapanis S, Elefsiniotis I, Kafiri G and Moulakakis A: Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B. Eur J Dermatol. 15:107–109. 2005.PubMed/NCBI

Patel U, Mark NM, Machler BC and Levine VJ: Imiquimod 5% cream induced psoriasis: A case report, summary of the literature and mechanism. Br J Dermatol. 164:670–672. 2011.PubMed/NCBI View Article : Google Scholar

van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD, Cornelissen F, Mus AM, Florencia E, Prens EP and Lubberts E: Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. J Immunol. 182:5836–5845. 2009.PubMed/NCBI View Article : Google Scholar

Hida S, Ogasawara K, Sato K, Abe M, Takayanagi H, Yokochi T, Sato T, Hirose S, Shirai T, Taki S and Taniguchi T: CD8(+) T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon-alpha/beta signaling. Immunity. 13:643–655. 2000.PubMed/NCBI View Article : Google Scholar

Tracey D, Klareskog L, Sasso EH, Salfeld JG and Tak PP: Tumor necrosis factor antagonist mechanisms of action: A comprehensive review. Pharmacol Ther. 117:244–279. 2008.PubMed/NCBI View Article : Google Scholar

Uyemura K, Yamamura M, Fivenson DF, Modlin RL and Nickoloff BJ: The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. J Invest Dermatol. 101:701–705. 1993.PubMed/NCBI View Article : Google Scholar

Mocanu M, Toader MP, Rezus E and Taranu T: Aspects concerning patient adherence to anti-TNFα therapy in psoriasis: A decade of clinical experience. Exp Ther Med. 18:4987–4992. 2019.PubMed/NCBI View Article : Google Scholar

Menter A, Tyring SK, Gordon K, Kimball AB, Leonardi CL, Langley RG, Strober BE, Kaul M, Gu Y, Okun M and Papp K: Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial. J Am Acad Dermatol. 58:106–115. 2008.PubMed/NCBI View Article : Google Scholar

Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, Zitnik R, van de Kerkhof PCM and Melvin L: Etanercept psoriasis study group. A global phase III randomized controlled trial of etanercept in psoriasis: Safety, efficacy, and effect of dose reduction. Br J Dermatol. 152:1304–1312. 2005.PubMed/NCBI View Article : Google Scholar

Blauvelt A, Reich K, Lebwohl M, Burge D, Arendt C, Peterson L, Drew J, Rolleri R and Gottlieb AB: Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: Pooled analysis of week 16 data from three randomized controlled trials. J Eur Acad Dermatol Venereol. 33:546–552. 2019.PubMed/NCBI View Article : Google Scholar

Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M and Krueger JG: Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med. 199:125–130. 2004.PubMed/NCBI View Article : Google Scholar

Haider AS, Lowes MA, Suárez-Fariñas M, Zaba LC, Cardinale I, Khatcherian A, Novitskaya I, Wittkowski KM and Krueger JG: Identification of cellular pathways of ‘type 1,’ Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasis. J Immunol. 180:1913–1920. 2008.PubMed/NCBI View Article : Google Scholar

Mahil SK, Capon F and Barker JN: Update on psoriasis immunopathogenesis and targeted immunotherapy. Semin Immunopathol. 38:11–27. 2016.PubMed/NCBI View Article : Google Scholar

Grechin C, Solovăstru LG, Vâță D, Pătrașcu AI, Grăjdeanu AI and Porumb-Andrese E: Inflammatory marker alteration in response to systemic therapies in psoriasis. Exp Ther Med. 20:42–46. 2020.PubMed/NCBI View Article : Google Scholar

Chan JR, Blumenschein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S, Lucian L, Geissler R, Brodie S, Kimball AB, et al: IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med. 203:2577–2587. 2006.PubMed/NCBI View Article : Google Scholar

Chamian F, Lowes MA, Lin SL, Lee E, Kikuchi T, Gilleaudeau P, Sullivan-Whalen M, Cardinale I, Khatcherian A, Novitskaya I, et al: Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci USA. 102:2075–2080. 2005.PubMed/NCBI View Article : Google Scholar

Rizzo HL, Kagami S, Phillips KG, Kurtz SE, Jacques SL and Blauvelt A: IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J Immunol. 186:1495–1502. 2011.PubMed/NCBI View Article : Google Scholar

Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J and Ouyang W: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 445:648–651. 2007.PubMed/NCBI View Article : Google Scholar

Tonel G, Conrad C, Laggner U, Di Meglio P, Grys K, McClanahan TK, Blumenschein WM, Qin JZ, Xin H, Oldham E, et al: Cutting edge: A critical functional role for IL-23 in psoriasis. J Immunol. 185:5688–5691. 2010.PubMed/NCBI View Article : Google Scholar

Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP and Krueger JG: Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol. 128:1207–1211. 2008.PubMed/NCBI View Article : Google Scholar

Szabo SK, Hammerberg C, Yoshida Y, Bata-Csorgo Z and Cooper KD: Identification and quantitation of interferon-gamma Producing T cells in psoriatic lesions: Localization to Both CD4+ and CD8+ Subsets. J Invest Dermatol. 111:1072–1078. 1998.PubMed/NCBI View Article : Google Scholar

Kulig P, Musiol S, Freiberger SN, Schreiner B, Gyülveszi G, Russo G, Pantelyushin S, Kishihara K, Alessandrini F, Kündig T, et al: IL-12 protects from psoriasiform skin inflammation. Nat Commun. 7(13466)2016.PubMed/NCBI View Article : Google Scholar

Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, Dooley LT and Lebwohl M: CNTO 1275 Psoriasis Study Group. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med. 356:580–592. 2007.PubMed/NCBI View Article : Google Scholar

Lanna C, Mancini M, Gaziano R, Cannizzaro MV, Galluzzo M, Talamonti M, Rovella V, Annicchiarico-Petruzzelli M, Melino G, Wang Y, et al: Skin immunity and its dysregulation in psoriasis. Cell Cycle. 18:2581–2589. 2019.PubMed/NCBI View Article : Google Scholar

Nikaein A, Phillips C, Gilbert SC, Savino D, Silverman A, Stone MJ and Menter A: Characterization of skin-infiltrating lymphocytes in patients with psoriasis. J Invest Dermatol. 96:3–9. 1991.PubMed/NCBI View Article : Google Scholar

Nickoloff BJ and Wrone-Smith T: Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol. 155:145–158. 1999.PubMed/NCBI View Article : Google Scholar

Gottlieb AB, Lebwohl M, Shirin S, Sherr A, Gilleaudeau P, Singer G, Solodkina G, Grossman R, Gisoldi E, Phillips S, et al: Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: Results of a pilot, multicenter, multiple-dose, placebo-controlled study. J Am Acad Dermatol. 43:595–604. 2000.PubMed/NCBI View Article : Google Scholar

Di Cesare A, Di Meglio P and Nestle FO: The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 129:1339–1350. 2009.PubMed/NCBI View Article : Google Scholar

Chiricozzi A, Guttman-Yassky E, Suárez-Fariñas M, Nograles KE, Tian S, Cardinale I, Chimenti S and Krueger JG: Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol. 131:677–687. 2011.PubMed/NCBI View Article : Google Scholar

Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M and Blauvelt A: Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: Implications for psoriasis pathogenesis. J Invest Dermatol. 129:2175–2183. 2009.PubMed/NCBI View Article : Google Scholar

Teunissen MB, Koomen CW, de Waal Malefyt R, Wierenga EA and Bos JD: Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol. 111:645–649. 1998.PubMed/NCBI View Article : Google Scholar

Kagami S, Rizzo HL, Lee JJ, Koguchi Y and Blauvelt A: Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol. 130:1373–1383. 2010.PubMed/NCBI View Article : Google Scholar

Tesmer LA, Lundy SK, Sarkar S and Fox DA: Th17 cells in human disease. Immunol Rev. 223:87–113. 2008.PubMed/NCBI View Article : Google Scholar

Priyadarssini M, Divya Priya D, Indhumathi S, Rajappa M, Chandrashekar L and Thappa DM: Immunophenotyping of T cells in the peripheral circulation in psoriasis. Br J Biomed Sci. 73:174–179. 2016.PubMed/NCBI View Article : Google Scholar

Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CEM, Papp K, Puig L, Nakagawa H, Spelman L, Sigurgeirsson B, et al: Secukinumab in plaque psoriasis-results of two phase 3 trials. N Engl J Med. 371:326–338. 2014.PubMed/NCBI View Article : Google Scholar

Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, et al: Phase 3 trials of Ixekizumab in Moderate-to-Severe plaque psoriasis. N Engl J Med. 375:345–356. 2016.PubMed/NCBI View Article : Google Scholar

Papp KA, Merola JF, Gottlieb AB, Griffiths CEM, Cross N, Peterson L, Cioffi C and Blauvelt A: Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial. J Am Acad Dermatol. 79:277–286.e10. 2018.PubMed/NCBI View Article : Google Scholar

Lebwohl M, Strober B, Menter A, Gordon K, Weglowska J, Puig L, Papp K, Spelman L, Toth D, Kerdel F, et al: Phase 3 studies comparing brodalumab with ustekinumab in psoriasis. N Engl J Med. 373:1318–1328. 2015.PubMed/NCBI View Article : Google Scholar

Blauvelt A: T-Helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and Psoriasis. J Invest Dermatol. 128:1064–1067. 2008.PubMed/NCBI View Article : Google Scholar

Papp KA, Blauvelt A, Bukhalo M, Gooderham M, Krueger JG, Lacour JP, Menter A, Philipp S, Sofen H, Tyring S, et al: Risankizumab versus Ustekinumab for Moderate-to-severe plaque psoriasis. N Engl J Med. 376:1551–1560. 2017.PubMed/NCBI View Article : Google Scholar

Kurzeja M, Rudnicka L and Olszewska M: New interleukin-23 pathway inhibitors in dermatology: Ustekinumab, briakinumab, and secukinumab. Am J Clin Dermatol. 12:113–125. 2011.PubMed/NCBI View Article : Google Scholar

Alunno A, Carubbi F, Cafaro G, Pucci G, Battista F, Bartoloni E, Giacomelli R, Schillaci G and Gerli R: Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis. Expert Opin Biol Ther. 15:1727–1737. 2015.PubMed/NCBI View Article : Google Scholar

Papp KA, Menter A, Strober B, Langley RG, Buonanno M, Wolk R, Gupta P, Krishnaswami S, Tan H and Harness JA: Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: A Phase 2b randomized placebo-controlled dose-ranging study. Br J Dermatol. 167:668–677. 2012.PubMed/NCBI View Article : Google Scholar

Papp K, Gordon K, Thaçi D, Morita A, Gooderham M, Foley P, Girgis IG, Kundu S and Banerjee S: Phase 2 Trial of selective tyrosine kinase 2 inhibition in psoriasis. N Engl J Med. 379:1313–1321. 2018.PubMed/NCBI View Article : Google Scholar

Papp KA, Menter MA, Raman M, Disch D, Schlichting DE, Gaich C, Macias W, Zhang X and Janes JM: A randomized phase 2b trial of baricitinib, an oral Janus kinase (JAK) 1/JAK2 inhibitor, in patients with moderate-to-severe psoriasis. Br J Dermatol. 174:1266–1276. 2016.PubMed/NCBI View Article : Google Scholar

Murphy KM and Reiner SL: The lineage decisions of helper T cells. Nat Rev Immunol. 2:933–944. 2002.PubMed/NCBI View Article : Google Scholar

Wei L, Debets R, Hegmans JJ, Benner R and Prens EP: IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production. J Pathol. 187:358–364. 1999.PubMed/NCBI View Article : Google Scholar

Haider AS, Cohen J, Fei J, Zaba LC, Cardinale I, Toyoko K, Ott J and Krueger JG: Insights into gene modulation by therapeutic TNF and IFNgamma antibodies: TNF regulates IFNgamma production by T cells and TNF-regulated genes linked to psoriasis transcriptome. J Invest Dermatol. 128:655–666. 2008.PubMed/NCBI View Article : Google Scholar

Conrad C, Boyman O, Tonel G, Tun-Kyi A, Laggner U, de Fougerolles A, Kotelianski V, Gardner H and Nestle FO: Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med. 13:836–842. 2007.PubMed/NCBI View Article : Google Scholar

Ortega C, Fernández-A S, Carrillo JM, Romero P, Molina IJ, Moreno JC and Santamaría M: IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines. J Leukoc Biol. 86:435–443. 2009.PubMed/NCBI View Article : Google Scholar

Liang Y, Pan HF and Ye DQ: IL-17A-producing CD8(+)T cells as therapeutic targets in autoimmunity. Expert Opin Ther Targets. 19:651–661. 2015.PubMed/NCBI View Article : Google Scholar

Opferman JT and Kothari A: Anti-apoptotic BCL-2 family members in development. Cell Death Differ. 25:37–45. 2018.PubMed/NCBI View Article : Google Scholar

Pekarsky Y, Balatti V and Croce CM: BCL2 and miR-15/16: From gene discovery to treatment. Cell Death Differ. 25:21–26. 2018.PubMed/NCBI View Article : Google Scholar

Montero J and Letai A: Why do BCL-2 inhibitors work and where should we use them in the clinic? Cell Death Differ. 25:56–64. 2018.PubMed/NCBI View Article : Google Scholar

Rose AM, Sansom OJ and Inman GJ: Loss of TGF-β signaling drives cSCC from skin stem cells-More evidence. Cell Cycle. 16:386–387. 2017.PubMed/NCBI View Article : Google Scholar

Yuan Y, Ding D, Zhang N, Xia Z, Wang J, Yang H, Guo F and Li B: TNF-α induces autophagy through ERK1/2 pathway to regulate apoptosis in neonatal necrotizing enterocolitis model cells IEC-6. Cell Cycle. 17:1390–1402. 2018.PubMed/NCBI View Article : Google Scholar

Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, Meyer zum Büschenfelde KH and Fleischer B: T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol. 102:145–149. 1994.PubMed/NCBI View Article : Google Scholar

Jacob SE, Nassiri M, Kerdel FA and Vincek V: Simultaneous measurement of multiple Th1 and Th2 serum cytokines in psoriasis and correlation with disease severity. Mediators Inflamm. 12:309–313. 2003.PubMed/NCBI View Article : Google Scholar

Fierlbeck G, Rassner G and Müller C: Psoriasis induced at the injection site of recombinant interferon gamma: Results of immunohistologic investigations. Arch Dermatol. 126:351–355. 1990.PubMed/NCBI

Cheuk S, Wikén M, Blomqvist L, Nylén S, Talme T, Ståhle M and Eidsmo L: Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis. J Immunol. 192:3111–3120. 2014.PubMed/NCBI View Article : Google Scholar

Lin WJ, Norris DA, Achziger M, Kotzin BL and Tomkinson B: Oligoclonal expansion of intraepidermal T cells in psoriasis skin lesions. J Invest Dermatol. 117:1546–1553. 2001.PubMed/NCBI View Article : Google Scholar

Takamura S: Niches for the long-term maintenance of tissue-resident memory T cells. Front Immunol. 9(1214)2018.PubMed/NCBI View Article : Google Scholar

Wu H, Liao W, Li Q, Long H, Yin H, Zhao M, Chan V, Lau CS and Lu Q: Pathogenic role of tissue-resident memory T cells in autoimmune diseases. Autoimmun Rev. 17:906–911. 2018.PubMed/NCBI View Article : Google Scholar

Clark RA, Chong B, Mirchandani N, Brinster NK, Yamanaka KI, Dowgiert RK and Kupper TS: The vast majority of CLA+ T cells are resident in normal skin. J Immunol. 176:4431–4439. 2006.PubMed/NCBI View Article : Google Scholar

Casey KA, Fraser KA, Schenkel JM, Moran A, Abt MC, Beura LK, Lucas PJ, Artis D, Wherry EJ, Hogquist K, et al: Antigen-independent differentiation and maintenance of effector-like resident memory T cells in tissues. J Immunol. 188:4866–4875. 2012.PubMed/NCBI View Article : Google Scholar

Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon ML, Vega-Ramos J, Lauzurica P, Mueller SN, Stefanovic T, et al: The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol. 14:1294–1301. 2013.PubMed/NCBI View Article : Google Scholar

Owczarczyk Saczonek A, Krajewska-Włodarczyk M, Kasprowicz-Furmańczyk M and Placek W: Immunological memory of psoriatic lesions. Int J Mol Sci. 21(625)2020.PubMed/NCBI View Article : Google Scholar

Milner JJ and Goldrath AW: Transcriptional programming of tissue-resident memory CD8+ T cells. Curr Opin Immunol. 51:162–169. 2018.PubMed/NCBI View Article : Google Scholar

Eberle FC, Brück J, Holstein J, Hirahara K and Ghoreschi K: Recent advances in understanding psoriasis. F1000Res. 5(F1000 Faculty Rev-770)2016.PubMed/NCBI View Article : Google Scholar

Patra V, Laoubi L, Nicolas JF, Vocanson M and Wolf P: A Perspective on the interplay of ultraviolet-radiation, skin microbiome and skin resident memory TCRαβ+ cells. Front Med (Lausanne). 5(166)2018.PubMed/NCBI View Article : Google Scholar

Clark RA: Resident memory T cells in human health and disease. Sci Transl Med. 7(269rv1)2015.PubMed/NCBI View Article : Google Scholar

Mueller SN, Zaid A and Carbone FR: Tissue-Resident T Cells: Dynamic players in skin immunity. Front Immunol. 5(332)2014.PubMed/NCBI View Article : Google Scholar

Corgnac S, Boutet M, Kfoury M, Naltet C and Mami-Chouaib F: The Emerging Role of CD8+ tissue resident memory T (TRM) cells in antitumor immunity: A unique functional contribution of the CD103 integrin. Front Immunol. 9(1904)2018.PubMed/NCBI View Article : Google Scholar

Kurihara K, Fujiyama T, Phadungsaksawasdi P, Ito T and Tokura Y: Significance of IL-17A-producing CD8+CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course. J Dermatol Sci. 95:21–27. 2019.PubMed/NCBI View Article : Google Scholar

Walsh D, Borges da Silva H, Beura L, Peng C, Hamilton S, Masopust D and Jameson S: The functional requirement for CD69 in establishment of resident memory CD8 + T cells varies with tissue location. J Immunol. 203:946–955. 2019.PubMed/NCBI View Article : Google Scholar

Mackay LK, Braun A, Macleod BL, Collins N, Tebartz C, Bedoui S, Carbone FR and Gebhardt T: Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention. J Immunol. 194:2059–2063. 2015.PubMed/NCBI View Article : Google Scholar

Schenkel JM and Masopust D: Tissue-resident memory T cells. Immunity. 41:886–897. 2014.PubMed/NCBI View Article : Google Scholar

Cheuk S, Schlums H, Gallais Sérézal I, Martini E, Chiang SC, Marquardt N, Gibbs A, Detlofsson E, Introini A, Forkel M, et al: CD49a expression defines Tissue-resident CD8+ T cells poised for cytotoxic function in human skin. Immunity. 46:287–300. 2017.PubMed/NCBI View Article : Google Scholar

Seidel JA, Vukmanovic-Stejic M, Muller-Durovic B, Patel N, Fuentes-Duculan J, Henson SM, Krueger JG, Rustin MHA, Nestle FO, Lacy KE and Akbar AN: Skin resident memory CD8⁺ T cells are phenotypically and functionally distinct from circulating populations and lack immediate cytotoxic function. Clin Exp Immunol. 194:79–92. 2018.PubMed/NCBI View Article : Google Scholar

Petrelli A and van Wijk F: CD8(+) T cells in human autoimmune arthritis: The unusual suspects. Nat Rev Rheumatol. 12:421–428. 2016.PubMed/NCBI View Article : Google Scholar

Ritchlin C: Tissue-resident memory T cells: Sequestered immune sensors and effectors of inflammation in Spondyloarthritis. Arthritis Rheumatol. 72:379–382. 2020.PubMed/NCBI View Article : Google Scholar

Adachi T, Kobayashi T, Sugihara E, Yamada T, Ikuta K, Pittaluga S, Saya H, Amagai M and Nagao K: Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 21:1272–1279. 2015.PubMed/NCBI View Article : Google Scholar

Diani M, Galasso M, Cozzi C, Sgambelluri F, Altomare A, Cigni C, Frigerio E, Drago L, Volinia S, Granucci F, et al: Blood to skin recirculation of CD4+ memory T cells associates with cutaneous and systemic manifestations of psoriatic disease. Clin Immunol. 180:84–94. 2017.PubMed/NCBI View Article : Google Scholar

Matos TR, O'Malley JT, Lowry EL, Hamm D, Kirsch IR, Robins HS, Kupper TS, Krueger JG and Clark RA: Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing αβ T cell clones. J Clin Invest. 127:4031–4041. 2017.PubMed/NCBI View Article : Google Scholar

Meglio PD, Villanova F, Navarini AA, Mylonas A, Tosi I, Nestle FO and Conrad C: Targeting CD8+ T cells prevents psoriasis development. J Allergy Clin Immunol. 138:274–276.e6. 2016.PubMed/NCBI View Article : Google Scholar

Farber DL, Yudanin NA and Restifo NP: Human memory T cells: Generation, compartmentalization and homeostasis. Nat Rev Immunol. 14:24–35. 2014.PubMed/NCBI View Article : Google Scholar

Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M and Nestle FO: Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis Factor-alpha. J Exp Med. 199:731–736. 2004.PubMed/NCBI View Article : Google Scholar

Campbell JJ, Clark RA, Watanabe R and Kupper TS: Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: A biologic rationale for their distinct clinical behaviors. Blood. 116:767–771. 2010.PubMed/NCBI View Article : Google Scholar

Gallais Sérézal I, Classon C, Cheuk S, Barrientos-Somarribas M, Wadman E, Martini E, Chang D, Landén NX, Ehrström M, Nylén S and Eidsmo L: Resident T cells in resolved psoriasis steer tissue responses that stratify clinical outcome. J Invest Dermatol. 138:1754–1763. 2018.PubMed/NCBI View Article : Google Scholar

Sérézal IG, Hoffer E, Ignatov B, Martini E, Zitti B, Ehrström M and Eidsmo L: A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional skin from patients with psoriasis. J Allergy Clin Immunol. 143:1444–1454. 2019.PubMed/NCBI View Article : Google Scholar

Vo S, Watanabe R, Koguchi-Yoshioka H, Matsumura Y, Ishitsuka Y, Nakamura Y, Okiyama N, Fujisawa Y and Fujimoto M: CD8 resident memory T cells with interleukin 17A-producing potential are accumulated in disease-naïve nonlesional sites of psoriasis possibly in correlation with disease duration. Br J Dermatol. 181:410–412. 2019.PubMed/NCBI View Article : Google Scholar

Diani M, Altomare G and Reali E: T Helper cell subsets in clinical manifestations of psoriasis. J Immunol Res. 2016(e7692024)2016.PubMed/NCBI View Article : Google Scholar

Bosè F, Petti L, Diani M, Moscheni C, Molteni S, Altomare A, Rossi RL, Talarico D, Fontana R, Russo V, et al: Inhibition of CCR7/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis. Am J Pathol. 183:413–421. 2013.PubMed/NCBI View Article : Google Scholar

Watanabe R: Protective and pathogenic roles of resident memory T cells in human skin disorders. J Dermatol Sci. 95:2–7. 2019.PubMed/NCBI View Article : Google Scholar

Sgambelluri F, Diani M, Altomare A, Frigerio E, Drago L, Granucci F, Banfi G, Altomare G and Reali E: A role for CCR5(+)CD4 T cells in cutaneous psoriasis and for CD103(+) CCR4(+) CD8 Teff cells in the associated systemic inflammation. J Autoimmun. 70:80–90. 2016.PubMed/NCBI View Article : Google Scholar

Chen L and Shen Z: Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders. Cell Mol Immunol. 17:64–75. 2020.PubMed/NCBI View Article : Google Scholar

Pan Y and Kupper TS: Metabolic reprogramming and longevity of tissue-resident memory T cells. Front Immunol. 9(1347)2018.PubMed/NCBI View Article : Google Scholar

Pearce EL, Walsh MC, Cejas PJ, Harms GM, Shen H, Wang LS, Jones RG and Choi Y: Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature. 460:103–107. 2009.PubMed/NCBI View Article : Google Scholar

Cui G, Staron MM, Gray SM, Ho PC, Amezquita RA, Wu J and Kaech SM: IL-7-induced glycerol transport and TAG synthesis promotes memory CD8+ T cell longevity. Cell. 161:750–761. 2015.PubMed/NCBI View Article : Google Scholar

Pan Y, Tian T, Park CO, Lofftus SY, Mei S, Liu X, Luo C, O'Malley JT, Gehad A, Teague JE, et al: Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature. 543:252–256. 2017.PubMed/NCBI View Article : Google Scholar

Esmaeili B, Mansouri P, Doustimotlagh AH and Izad M: Redox imbalance and IL-17 responses in memory CD4⁺ T cells from patients with psoriasis. Scand J Immunol. 89(e12730)2019.PubMed/NCBI View Article : Google Scholar

Karamehic J, Zecevic L, Resic H, Jukic M, Jukic T, Ridjic O, Panjeta M and Coric J: Immunophenotype lymphocyte of peripheral blood in patients with psoriasis. Med Arch. 68:236–238. 2014.PubMed/NCBI View Article : Google Scholar